Gelişmiş Arama

Basit öğe kaydını göster

CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients

dc.contributor.authorKaraaslan Z.
dc.contributor.authorKurtuncu M.
dc.contributor.authorAkcay H.I.
dc.contributor.authorGunduz T.
dc.contributor.authorAltunrende B.
dc.contributor.authorTurkoglu R.
dc.contributor.authorEraksoy M.
dc.date.accessioned2024-02-04T13:30:13Z
dc.date.available2024-02-04T13:30:13Z
dc.date.issued2022
dc.identifier.issn00143022
dc.identifier.urihttps://doi.org/10.1159/000517770
dc.identifier.urihttp://hdl.handle.net/11446/4870
dc.description.abstract[No abstract available]en_US
dc.description.sponsorshipNovartis Pharmaceuticals Corporation, NPCen_US
dc.description.sponsorshipThis study was sponsored by Novartis Pharmaceuticals.en_US
dc.language.isoengen_US
dc.publisherS. Karger AGen_US
dc.relation.ispartofEuropean Neurologyen_US
dc.identifier.doi10.1159/000517770
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCXCL13 chemokineen_US
dc.subjectcytokineen_US
dc.subjectfingolimoden_US
dc.subjectgamma interferon inducible protein 10en_US
dc.subjectinterleukin 22en_US
dc.subjectinterleukin 4en_US
dc.subjectinterleukin 8en_US
dc.subjectmonocyte chemotactic protein 1en_US
dc.subjectRANTESen_US
dc.subjecttumor necrosis factoren_US
dc.subjectCXCL13 chemokineen_US
dc.subjectCXCL13 protein, humanen_US
dc.subjectimmunosuppressive agenten_US
dc.subjectadulten_US
dc.subjectclinical articleen_US
dc.subjectcontrolled studyen_US
dc.subjectdemographicsen_US
dc.subjectdisease durationen_US
dc.subjectExpanded Disability Status Scaleen_US
dc.subjectfemaleen_US
dc.subjectfollow upen_US
dc.subjecthealth careen_US
dc.subjecthumanen_US
dc.subjectLetteren_US
dc.subjectmaleen_US
dc.subjectmultiple sclerosisen_US
dc.subjectrelapseen_US
dc.subjecttreatment responseen_US
dc.subjectChemokine CXCL13en_US
dc.subjectFingolimod Hydrochlorideen_US
dc.subjectHumansen_US
dc.subjectImmunosuppressive Agentsen_US
dc.subjectMultiple Sclerosisen_US
dc.titleCXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patientsen_US
dc.typeletteren_US
dc.departmentDBÜen_US
dc.identifier.issue1en_US
dc.identifier.volume85en_US
dc.identifier.startpage69en_US
dc.identifier.endpage71en_US
dc.relation.publicationcategoryDiğeren_US
dc.department-tempKaraaslan, Z., Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey; Kurtuncu, M., Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey; Akcay, H.I., Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey; Gunduz, T., Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey; Altunrende, B., Department of Neurology, Faculty of Medicine, Demiroglu Bilim University, Istanbul, Turkey; Turkoglu, R., Department of Neurology, Istanbul Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey; Eraksoy, M., Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey; Ulusoy, C., Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey; Yilmaz, V., Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey; Tüzün, E., Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkeyen_US
dc.identifier.pmid34340233en_US
dc.identifier.scopus2-s2.0-85112379348en_US
dc.authorscopusid55629365500
dc.authorscopusid6508110751
dc.authorscopusid55860330100
dc.authorscopusid55391001500
dc.authorscopusid24340580900
dc.authorscopusid26649267800
dc.authorscopusid6603420500


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster